|
1
|
Tao Z, Shi A, Lu C, Song T, Zhang Z and
Zhao J: Breast cancer: Epidemiology and etiology. Cell Biochem
Biophys. 72:333–338. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Coughlin S: Epidemiology of breast cancer
in women. Adv Exp Med Biol. 1152:9–29. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Winters S, Martin C, Murphy D and Shokar
N: Breast cancer epidemiology, prevention, and screening. Prog Mol
Biol Transl Sci. 151:1–32. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Harbeck N and Gnant M: Breast cancer.
Lancet. 389:1134–1150. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Carey L, Winer E, Viale G, Cameron D and
Gianni L: Triple-negative breast cancer: Disease entity or title of
convenience? Nat Rev Clin Oncol. 7:683–692. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liedtke C, Mazouni C, Hess K, André F,
Tordai A, Mejia J, Symmans WF, Gonzalez-Angulo A, Hennessy B, Green
M, et al: Response to neoadjuvant therapy and long-term survival in
patients with triple-negative breast cancer. J Clin Oncol.
26:1275–1281. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rakha EA, El-Sayed ME, Green AR, Lee AH,
Robertson JF and Ellis IO: Prognostic markers in triple-negative
breast cancer. Cancer. 109:25–32. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Denkert C, Liedtke C, Tutt A and von
Minckwitz G: Molecular alterations in triple-negative breast
cancer-the road to new treatment strategies. Lancet. 389:2430–2442.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Thomford NE, Senthebane DA, Rowe A, Munro
D, Seele P, Maroyi A and Dzobo K: Natural products for drug
discovery in the 21st century: Innovations for novel drug
discovery. Int J Mol Sci. 19:15782018. View Article : Google Scholar
|
|
10
|
Harvey AL: Natural products in drug
discovery. Drug Discov Today. 13:894–901. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen Y: Potential role of tetrandrine in
cancer therapy. Acta Pharmacol Sin. 23:1102–1106. 2002.PubMed/NCBI
|
|
12
|
Liu T, Liu X and Li W: Tetrandrine, a
Chinese plant-derived alkaloid, is a potential candidate for cancer
chemotherapy. Oncotarget. 7:40800–40815. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu B, Wang T, Qian X, Liu G, Yu L and
Ding Y: Anticancer effect of tetrandrine on primary cancer cells
isolated from ascites and pleural fluids. Cancer Lett. 268:166–175.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lu Y, Li F, Xu T and Sun J: Tetrandrine
prevents multidrug resistance in the osteosarcoma cell line, U-2OS,
by preventing Pgp overexpression through the inhibition of NF-κB
signaling. Int J Mol Med. 39:993–1000. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhu R, Liu T, Tan Z, Wu X, Li M, Jiang L,
Bao R, Shu Y, Lu A and Liu Y: Tetrandrine induces apoptosis in
gallbladder carcinoma in vitro. Int J Clin Pharmacol Ther.
52:900–905. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun XC, Cheng HY, Deng YX, Shao RG and Ma
J: Tetrandrine: A potent abrogator of G2 checkpoint function in
tumor cells and its mechanism. Biomed Environ Sci. 20:495–501.
2007.PubMed/NCBI
|
|
17
|
Qiu W, Zhang AL and Tian Y: Tetrandrine
triggers an alternative autophagy in DU145 cells. Oncol Lett.
13:3734–3738. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu WL, Shen HL, Ao ZF, Chen BA, Xia W, Gao
F and Zhang YN: Combination of tetrandrine as a potential-reversing
agent with daunorubicin, etoposide and cytarabine for the treatment
of refractory and relapsed acute myelogenous leukemia. Leuk Res.
30:407–413. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu W, Zhang J, Ying C, Wang Q, Yan C,
Jingyue Y, Zhaocai Y, Yan X, Heng-jun S and Lin J: Tetrandrine
combined with gemcitabine and cisplatin for patients with advanced
non-small cell lung cancer improve efficacy. Int J Biomed Sci.
8:28–35. 2012.PubMed/NCBI
|
|
20
|
Bailly C: Cepharanthine: An update of its
mode of action, pharmacological properties and medical
applications. Phytomedicine. 62:1529562019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Asaumi J, Nishikawa K, Matsuoka H, Iwata
M, Kawasaki S, Hiraki Y and Nishijima K: Direct antitumor effect of
cepharanthin and combined effect with adriamycin against Ehrlich
ascites tumor in mice. Anticancer Res. 15:67–70. 1995.PubMed/NCBI
|
|
22
|
Ono M and Tanaka N: Positive interaction
of bisbenzylisoquinoline alkaloid, cepharanthin, with vinca
alkaloid agents against human tumors. In Vivo. 11:233–241.
1997.PubMed/NCBI
|
|
23
|
Rosso F, Giordano A, Barbarisi M and
Barbarisi A: From cell-ECM interactions to tissue engineering. J
Cell Physiol. 199:174–180. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ryu N, Lee S and Park H: Spheroid culture
system methods and applications for mesenchymal stem cells. Cells.
8:16202019. View Article : Google Scholar
|
|
25
|
Breslin S and O'Driscoll L: The relevance
of using 3D cell cultures, in addition to 2D monolayer cultures,
when evaluating breast cancer drug sensitivity and resistance.
Oncotarget. 7:45745–45756. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Imamura Y, Mukohara T, Shimono Y,
Funakoshi Y, Chayahara N, Toyoda M, Kiyota N, Takao S, Kono S,
Nakatsura T and Minami H: Comparison of 2D- and 3D-culture models
as drug-testing platforms in breast cancer. Oncol Rep.
33:1837–1843. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Moscona A: Rotation-mediated histogenetic
aggregation of dissociated cells. A quantifiable approach to cell
interactions in vitro. Exp Cell Res. 22:455–475. 1961. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
O'Keane JC, Kupchik HZ, Schroy PC, Andry
CD, Collins E and O'Brien MJ: A three-dimensional system for
long-term culture of human colorectal adenomas. Am J Pathol.
137:1539–1547. 1990.PubMed/NCBI
|
|
29
|
Carlsson J, Nilsson K, Westermark B,
Pontén J, Sundström C, Larsson E, Bergh J, Påhlman S, Busch C and
Collins VP: Formation and growth of multicellular spheroids of
human origin. Int J Cancer. 31:523–533. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kleinman HK, McGarvey ML, Hassell JR, Star
VL, Cannon FB, Laurie GW and Martin GR: Basement membrane complexes
with biological activity. Biochemistry. 25:312–318. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lawler EM, Miller FR and Heppner GH:
Significance of three-dimensional growth patterns of mammary
tissues in collagen gels. In Vitro. 19:600–610. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bresciani G, Hofland LJ, Dogan F, Giamas
G, Gagliano T and Zatelli MC: Evaluation of spheroid 3D culture
methods to study a pancreatic neuroendocrine neoplasm cell line.
Front Endocrinol (Lausanne). 10:6822019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nath S and Devi G: Three-dimensional
culture systems in cancer research: Focus on tumor spheroid model.
Pharmacol Ther. 163:94–108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kelm JM, Timmins NE, Brown CJ, Fussenegger
M and Nielsen LK: Method for generation of homogeneous
multicellular tumor spheroids applicable to a wide variety of cell
types. Biotechnol Bioeng. 83:173–180. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vinci M, Gowan S, Boxall F, Patterson L,
Zimmermann M, Court W, Lomas C, Mendiola M, Hardisson D and Eccles
SA: Advances in establishment and analysis of three-dimensional
tumor spheroid-based functional assays for target validation and
drug evaluation. BMC Biol. 10:292012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu W, Wang X, Tu Y, Masaki H, Tanaka S,
Onda K, Sugiyama K, Yamada H and Hirano T: Tetrandrine and
cepharanthine induce apoptosis through caspase cascade regulation,
cell cycle arrest, MAPK activation and PI3K/Akt/mTOR signal
modification in glucocorticoid resistant human leukemia Jurkat T
cells. Chem Biol Interact. 130:1087262019. View Article : Google Scholar
|
|
37
|
Nigjeh SE, Yeap SK, Nordin N, Kamalideghan
B, Ky H and Rosli R: Citral induced apoptosis in MDA-MB-231
spheroid cells. BMC Complement Altern Med. 18:562018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jhan JR and Andrechek ER: Triple-negative
breast cancer and the potential for targeted therapy.
Pharmacogenomics. 18:1595–1609. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bhagya N and Chandrashekar KR:
Tetrandrine-A molecule of wide bioactivity. Phytochemistry.
125:5–13. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gatti R, Belletti S, Orlandini G,
Bussolati O, Dall'Asta V and Gazzola GC: Comparison of annexin V
and calcein-AM as early vital markers of apoptosis in adherent
cells by confocal laser microscopy. J Histochem Cytochem.
46:895–900. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Basmaciyan L, Azas N and Casanova M:
Calcein+/PI-as an early apoptotic feature in Leishmania. PLoS One.
12:e01877562017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Leung YM, Berdik M, Kwan CY and Loh TT:
Effects of tetrandrine and closely related bis-benzylisoquinoline
derivatives on cytosolic Ca2+ in human leukemic HL-60
cells: A structure-activity relationship study. Clin Exp Pharmacol
Physiol. 23:653–659. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kunz-Schughart L, Freyer J, Hofstaedter F
and Ebner R: The use of 3-D cultures for high-throughput screening:
The multicellular spheroid model. J Biomol Screen. 9:273–285. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kiyomi A, Makita M, Ozeki T, Li N,
Satomura A, Tanaka S, Onda K, Sugiyama K, Iwase T and Hirano T:
Characterization and clinical implication of Th1/Th2/Th17 cytokines
produced from three-dimensionally cultured tumor tissues resected
from breast cancer patients. Transl Oncol. 8:318–326. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Jo Y, Choi N, Kim K, Koo HJ, Choi J and
Kim HN: Chemoresistance of cancer cells: Requirements of tumor
microenvironment-mimicking in vitro models in anti-cancer drug
development. Theranostics. 8:5259–5275. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhou P, Li Z, Xu D, Wang Y, Bai Q, Feng Y,
Su G, Chen P, Wang Y, Liu H, et al: Cepharanthine hydrochloride
improves cisplatin chemotherapy and enhances immunity by regulating
intestinal microbes in mice. Front Cell Infect Microbiol.
9:2252019. View Article : Google Scholar : PubMed/NCBI
|
